Zusammenfassung
Die Prävalenz von HPV(humane Papillomaviren)-Infektionen ist im reproduktiven Alter besonders hoch. Infolgedessen sind die klinischen Auswirkungen einer persistierenden HPV-Infektion auch in der Schwangerschaft keine Seltenheit. Ziel der vorliegenden Arbeit ist es, konkrete Empfehlungen für den Umgang mit klinisch sichtbaren oder subklinischen HPV-Infektionen in der Schwangerschaft zu geben. Jede schwangere Patientin mit Auffälligkeiten in der Zervixzytologie sollte kolposkopiert werden. Die Indikation zur bioptischen Abklärung unter kolposkopischer Kontrolle in graviditate wird analog zum nichtgraviden Status gestellt. Kann ein invasives Zervixkarzinom in graviditate nicht ausgeschlossen werden, ist eine histologische Sicherung mittels Exzision bzw. Schlingenkonisation z. B. in der 16.–20. SSW empfohlen. Bei präinvasiven Veränderungen kann der Schwangerschaftsverlauf in der Regel abgewartet werden. Die Therapie eines invasiven Zervixkarzinoms in der Schwangerschaft ist eine individuelle, interdisziplinäre Entscheidung. Condylomata acuminata in der Schwangerschaft stellen in der Regel keine Indikation für eine primäre Sectio dar. Eine HPV-Impfung in der Schwangerschaft wird nicht empfohlen, es sind jedoch keine schwerwiegenden Komplikationen bei versehentlicher Impfung zu erwarten.
Abstract
Especially during reproductive age the prevalence of human papillomavirus (HPV) infection is high. Therefore clinical effects of a persistent HPV infection in pregnancy are commonly encountered. In this article specific suggestions for treatment of HPV infection in pregnancy are presented. All patients with abnormal cervical cytology in pregnancy should undergo a colposcopy. In case of suspected high-grade dysplasia or invasive cancer a target biopsy should be performed. In preinvasive lesions active surveillance during pregnancy is adequate without a need for surgical intervention. Therapy of invasive cervical cancer in pregnancy is an individual and interdisciplinary decision process. There is no indication for caesarean section due to Condylomata acuminata. HPV vaccination in pregnancy is not recommended, but in case of accidental vaccination no negative effects are to be expected.
Literatur
Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T (2008) Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 123(8):1864–1870. doi:10.1002/ijc.23712
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518–527
Petry KU, Luyten A, Justus A, Iftner A, Strehlke S, Reinecke-Lüthge A, Grunwald E, Schulze-Rath R, Iftner T (2013) Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84 – results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany. Bmc Infect Dis 13:135. doi:10.1186/1471-2334-13-135
Klug SJ, Hukelmann M, Hollwitz B, Düzenli N, Schopp B, Petry KU, Iftner T (2007) Prevalence of human papillomavirus types in women screened by cytology in Germany. J Med Virol 79(5):616–625
Al-Halal H, Kezouh A, Abenhaim HA (2013) Incidence and obstetrical outcomes of cervical intraepithelial neoplasia and cervical cancer in pregnancy: a population-based study on 8.8 million births. Arch Gynecol Obstet 287(2):245–250
http://www.awmf.org/uploads/tx_szleitlinien/2016-03-15_S3_LL_Prävention_des_Zervixkarzinoms__Konsultationsfassung.pdf. Zugegriffen: 31. März 2016
Brown DR, Bryan JT, Cramer H, Fife KH (1993) Analysis of human papillomavirus types in exophytic condylomata acuminata by hybrid capture and southern blot techniques. J Clin Microbiol 31(10):2667–2673
IARC (2012) A review of human carcinogens – biological agents. IARC Monogr Eval Carcinog Risks Hum. 100:255–313
Gravitt PE (2011) The known unknowns of HPV natural history. J Clin Invest 121(12):4593–4599. doi:10.1172/JCI57149
Miranda PM, Silva NN, Pitol BC, Silva ID, Lima-Filho JL, Carvalho RF, Stocco RC, Beçak W, Lima AA (2013) Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil. Biomed Res Int 2013:578276. doi:10.1155/2013/578276
Armbruster-Moraes E, Ioshimoto LM, Leão E, Zugaib M (1994) Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol Oncol 54(2):152–158
Loyo M, Pai SI, Netto GJ, Tunkel DE (2008) Aggressive recurrent respiratory papillomatosis in a neonate. Int J Pediatr Otorhinolaryngol 72(6):917–920. doi:10.1016/j.ijporl.2008.02.022
Castellsagué X, Drudis T, Cañadas MP, Goncé A, Ros R, Pérez JM, Quintana MJ, Muñoz J, Albero G, de Sanjosé S, Bosch FX (2009) Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain. Bmc Infect Dis 27(9):74. doi:10.1186/1471-2334-9-74
Khaengkhor P, Mairaing K, Suwannarurk K, Thaweekul Y, Poomtavorn Y, Pattaraarchachai J, Bhamarapravatana K (2011) Prevalence of abnormal cervical cytology by liquid based cytology in the antenatal care clinic, Thammasat University Hospital. J Med Assoc Thai 94(2):152–158
Goncalves CV et al (2009) Diagnosis and treatment of cervical cancer during pregnancy. Sao Paulo Med J 127(6):359–365
Fader AN, Alward EK, Niederhauser A et al (2010) Cervical dysplasia in pregnancy: a multiinstitutional evaluation. Am J Obstet Gynecol 203(2):113 e1–113 e6
Lellè R, Küppers V (2008) Kolposkopie in der Praxis. Springer, Heidelberg
Yost NP, Santoso JT, McIntire DD, Iliya FA (1999) Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol 93(3):359–362
Vlahos G, Rodolakis A, Diakomanolis E, Stefanidis K, Haidopoulos D, Abela K, Georgountzos V, Michalas S (2002) (2002). Conservative management of cervical intraepithelial neoplasia (CIN(2–3)) in pregnant women. Gynecol Obstet Invest 54(2):78–81
Paraskevaidis E, Koliopoulos G, Kalantaridou S et al (2002) Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum. Eur J Obstet Gynecol Reprod Biol 104(1):67–69
Robinson WR, Webb S, Tirpack J, Degefu S, O’Quinn AG (1997) Management of cervical intraepithelial neoplasia during pregnancy with LOOP excision. Gynecol Oncol 64(1):153–155
Kaplan KJ, Dainty LA, Dolinsky B et al (2004) Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesions diagnosed during pregnancy. Cancer 102(4):228–232
Mitsuhashi A, Sekiya S (2000) Loop electrosurgical excision procedure (LEEP) during first trimester of pregnancy. Int J Gynaecol Obstet 71(3):237–239
Henning U et al (2002) Der verdächtige Abstrich in der Schwangerschaft. Dtsch Arztebl 99:A2047–A2051
www.awmf.org/uploads/tx_szleitlinien/032-033OLl_S3_Zervixkarzinom_2014-10.pdf. Zugegriffen: 31. März 2016
Van Calsteren K et al (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28(4):683–689
Căpîlna ME, Szabo B, Becsi J (2016) Radical trachelectomy performed during pregnancy: a review of the literature. Int J Gynecol Cancer 26:758
Sood AK, Sorosky JI (1998) Invasive cervical cancer complicating pregnancy. How to manage the dilemma. Obstet Gynecol Clin North Am 25(2):343–352
Loibl S, Han SN, von Minckwitz G et al (2012) Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol 13(9):887–896. doi:10.1016/S1470-2045(12)70261-9
Sood AK, Sorosky JI, Mayr N, Anderson B, Buller RE, Niebyl J (2000) Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes. Obstet Gynecol 95(6 Pt 1):832–838
Köhler C, Oppelt P, Favero G, Morgenstern B, Runnebaum I, Tsunoda A, Schmittel A, Schneider A, Mueller M, Marnitz S (2015) How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy. Am J Obstet Gynecol 213(2):206.e1–206.e5. doi:10.1016/j.ajog.2015.02.022
Koutsky L (1997) Epidemiology of genital human papillomavirus infection. Am J Med 102(5A):3–8
Hillemanns P, Breugelmans JG, Gieseking F, Bénard S, Lamure E, Littlewood KJ, Petry KU (2008) Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. BMC Infect Dis. doi:10.1186/1471-2334-8-76
Leitlinie der Deutschen STD-Gesellschaft (2010): Condylomata acuminata und andere HPV-assoziierte Krankheitsbilder von Genitale, Anus und Harnröhre
Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV (2003) Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 101(4):645–652
Hillemanns P (2014) Ist eine HPV-Impfung nach Konisation sinnvoll? Geburtshilfe Frauenheilkd 74:710–711
The college of Family Physicians of Canada (2012) Human papillomavirus vaccine and pregnancy. Can Fam Physician 58(3):268–269
Ackermann S, Gehrsitz C, Mehlhorn G, Beckmann MW (2006) Management and course of histologically verified cervical carcinoma in situ during pregnancy. Acta Obstet Gynecol Scand 85(9):1134–1137
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Hillemanns erhielt Vortragshonorare von SPMSD, Roche, Hologic. Die Frauenklinik der MHH erhielt Forschungsunterstützung durch GSK, Abbott. C. Goldnau gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
R. Kimmig, Essen
A. Köninger, Essen
I. Mylonas, München
Rights and permissions
About this article
Cite this article
Goldnau, C., Hillemanns, P. HPV-Infektion in der Schwangerschaft. Gynäkologe 49, 599–606 (2016). https://doi.org/10.1007/s00129-016-3917-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-016-3917-y